drugset / Trial / NCT01242228
A Study to Assess the Safety and Efficacy of ASP1941 in Combination With Dipeptidyl Peptidase-4 (DPP-4) Inhibitor in Type 2 Diabetic Patients
NaSingle-groupOpen-labelTreatment
Summary
This study is to evaluate long-term safety and efficacy after concomitant administration of ASP1941 and DPP-4 inhibitor in Japanese patients with type 2 diabetes mellitus.
Timeline
- Start
- 2010-10-21
- Primary completion
- 2012-06-06
- Completion
- 2012-06-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ipragliflozin | Small molecule | — | Oral |
| Background | Alogliptin | Unknown | — | Oral |
| Background | SAXAGLIPTIN ANHYDROUS | Small molecule | — | Oral |
| Background | Sitagliptin | Small molecule | — | Oral |
| Background | Vildagliptin | Other / unclassified | — | Oral |